Sweet N Sour: Stratifying low-calorie sweeteners for type 2 diabetes risk

This study is designed to investigate whether different low-calorie sweeteners are more or less prone to affect blood glucose control. We will also test which sweeteners affect glucose absorption from the intestine, and whether they alter the types and amount of bacteria present in the intestine.

Study Purpose/Description

A range of low-calorie (or “non-nutritive”) sweeteners have been used as “healthy” substitutes for sugar in foods and beverages. However, large population studies suggest that regular intake of these sweeteners can increase the risk of developing type 2 diabetes. Whether some sweeteners are better than others remains unclear.

We will supplement study participants with one of five low-calorie sweeteners (acesulfame-K, aspartame, stevia, sucralose, saccharin) or placebo, provided in capsules over 4 weeks, and assess the impact of these sweeteners on blood glucose control and the absorption of glucose from the intestine, and whether they modify the bacteria present in the intestines.

What’s involved?

The study requires 4 study visits, each lasting 4-5 hours, at the Adelaide Health and Medical Sciences (AHMS) building. Two of these visits will involve collection of blood and breath samples following a glucose drink. The other two involve infusion of glucose into the small intestine through a soft tube inserted through the nose, with collection of blood and urine samples. We will also be collecting information about food intake using diet diaries, and will collect a stool sample at the beginning and end of the study.

Upon completion of our study (Approx. 5 week duration from beginning to end with four half day study visits), participants will receive an honorarium of up to $350 via EFT transfer.

Want to learn more?

If you are interested and think you might be eligible, you can:

Recruitment criteria

You may be eligible to participate in this study if:

  • aged 18-70 living in South Australia
  • have not been diagnosed with diabetes or pre-diabetes
  • no significant health issues or medications that may influence gastrointestinal motor function, body weight or appetite
  • no kidney or liver disease, or iron deficiencies
  • smoke less than 10 cigarettes a day
  • not pregnant, breastfeeding

Benefits

Upon completion of our study (Approx. 5 week duration from beginning to end with four half day study visits), participants will receive an honorarium of up to $350 via EFT transfer.

Study sponsor / funder

Research team contacts

08 8313 6676

Register your interest


    Please sign up on Join Us here
    You need to be registerd to deterime if you quilify for the study